Macrogenics (MGNX) Current Assets (2012 - 2026)

Macrogenics (MGNX) has reported Current Assets for 15 consecutive years, with $182.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets changed 0.24% year-over-year to $182.5 million; the TTM figure through Mar 2026 stood at $182.5 million (changed 0.24% YoY), while the FY2025 annual figure was $219.9 million, up 1.13% from the prior year.
• Current Assets slipped to $182.5 million in Q1 2026 per MGNX's latest filing, from $219.9 million in the prior quarter.
• Across five years, Current Assets topped out at $291.3 million in Q3 2023 and bottomed at $147.8 million in Q3 2022.
• Historically, Current Assets has averaged $215.5 million across 5 years, with a median of $218.2 million in 2022.
• Annual changes were most pronounced in 2022 — Current Assets plunged 55.84% — and 2023, when it soared 97.09%.
• Macrogenics' Current Assets stood at $222.2 million in 2022, then rose by 13.12% to $251.3 million in 2023, then decreased by 13.47% to $217.5 million in 2024, then rose by 1.13% to $219.9 million in 2025, then slipped by 17.01% to $182.5 million in 2026.
• Business Quant data shows MGNX's Current Assets at $182.5 million in Q1 2026, $219.9 million in Q4 2025, and $232.1 million in Q3 2025.